Advertisement

Topics

eTherapeutics Plc ETX Financial and Strategic SWOT Analysis Review [Report Updated: 01082017] Prices from USD $125

15:54 EDT 20 Aug 2017 | BioPortfolio Reports

eTherapeutics Plc ETX Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description A detailed description of the company's operations and business divisions.
Corporate strategy Analyst's summarization of the company's business strategy.
SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history Progression of key events associated with the company.
Major products and services A list of major products, services and brands of the company.
Key competitors A list of key competitors to the company.
Key employees A list of the key executives of the company.
Executive biographies A brief summary of the executives' employment history.
Key operational heads A list of personnel heading key departments/functions.
Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.

Highlights

eTherapeutics Plc eTherapeutics is a drug discovery and development company with focus on the treatment of cancer and neurodegeneration. It has a proprietary discovery platform based on network pharmacology and chemical biology for the discovery of drugs. The company focuses on immunooncology to tackle drug resistance in targeted cancer therapies and antiinfectives. Its pipeline candidates include ETX1153c an antibiotic, ETS2101 and ETS6103. eTherapeutics has development centers in Oxford and Newcastle. The company operates through one subsidiary, InRotis Technologies Limited. eTherapeutics is headquartered in Long Hanborough, England, the UK.

eTherapeutics Plc Key Recent Developments

Jul 24,2017: eTherapeutics Announces Outcome of Strategic Review and Future Plans
Apr 19,2017: eTherapeutics: Full Year Results
Apr 06,2017: eTherapeutics : Appointment of Chief Executive Officer
Feb 16,2017: eTherapeutics Announces Directorate Change
Jan 09,2017: eTherapeutics: Appointment of Amgen Executive Director as Chief Executive

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Original Article: eTherapeutics Plc ETX Financial and Strategic SWOT Analysis Review [Report Updated: 01082017] Prices from USD $125

NEXT ARTICLE

More From BioPortfolio on "eTherapeutics Plc ETX Financial and Strategic SWOT Analysis Review [Report Updated: 01082017] Prices from USD $125"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...